Oventus Medical Ltd (ASX:OVN) is pleased to announce the Canadian launch of the O2Vent (R) Optima device which treats both the potentially fatal condition, obstructive sleep apnoea and snoring. The ...

IRVINE, Calif. – Oventus Medical has reported interim financial results for the six months ended Dec. 31, 2021, including $554,000 in revenue. The company, which makes the O2Vent oral device to treat ...

Brisbane, May 5, 2017 - (ABN Newswire) - Australian medical device company Oventus Medical Ltd. (ASX:OVN), has lodged an FDA 510k submission for its O2Vent W device - an oral appliance intended to ...

Brisbane based medical device company, Oventus Medical will launch their new Victorian 3D printing facility at CSIRO today. The additive manufacturing plant that uses titanium 3D printing technology ...

Brisbane, April 4, 2017 AEST (ABN Newswire) - Oventus Medical Ltd (ASX:OVN) are pleased to provide the Company's latest Investor Update. - Oventus Manufacturing receives Certificate of Registration ...

Oventus Medical Ltd (ASX:OVN) is pleased to announce the launch of the O2Vent(R) Optima device in Australia, an important addition to the Company's sleep treatment platform. Key points: - New Oventus ...

Oventus Medical Ltd (ASX:OVN) is pleased to announce the Canadian launch of the O2Vent(R) Optima device which treats both the potentially fatal condition, obstructive sleep apnoea (OSA) and snoring.